StartUPDATES is a member feature of MedCitizens, a community of MedCity News startups. Submit here and join.
On the heels of announcing a new partnership with Premera Blue Cross, predictive healthcare analytics company Cardinal Analytx Solutions added two strategic additions to its executive team: Dr. Chris DeRienzo, MD, MPP, FAAP, as chief medical officer, and Niall O’Cathasaigh as chief financial officer.
Inside an Automated Healthcare Practice: Redesigning Care Around People, Not Paperwork
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.
“Chris and Niall each brings crucial skills and experience at this pivotal point in the evolution of Cardinal as our market traction is growing rapidly,” said CEO Linda T. Hand. “The value of machine learning in transforming healthcare is clear, and both are passionate about realizing our shared vision of delivering better care to patients sooner.”
Recognized by Modern Healthcare in 2018 as one of 15 “Up and Comers Under 40,” Dr. DeRienzo has become an international leader in the use of data science in healthcare at the intersection of humanity and technology. He most recently served as chief quality officer for Mission Health, an integrated delivery system based in Asheville, North Carolina.
O’Cathasaigh served as the company’s consulting CFO for 18 months before taking on the role permanently. He has worked as a founder and consultant with startups and growth-stage companies in the U.S., Europe and Africa for more than 20 years.
The SEC has qualified Insitu Biologics’s 2:1 post-split share price of $8.00. The company is only offering 50,000 shares at this price. You can find all of the Offering Materials by going to: https://www. manhattanstreetcapital.com/ insitu-biologics-0
Beyond Analytics: How Sellers Dorsey is Hard-Coding Value into Medicaid Policy [Video]
How to turn analytics into actual policy outcomes.
Solera Health, which builds networks of evidence-based programs that improve health and well-being, has signed a new partnership with the Blue Cross Blue Shield Institute to address social determinants of health. Solera has been piloting its partnership with BCBS Institute in a few key markets and plans to roll out increased capabilities over the rest of the year. Click here to read more.
Xealth, a digital health startup with a digital prescribing platform, has secured an $11 million Series A round. Novartis, Philips, McKesson Ventures and ResMed took part in the funding round, as did existing investors Threshold Ventures (formerly known as DFJ), Providence Ventures, UPMC and Froedtert & the Medical College of Wisconsin health Network. Click here to read more.
Cleo, a startup that was formed to ease the transition of new parents back into the workforce, has raised a $27.5 million Series B funding round led by NEA to support the growth of its parental support platform. Click here to read more.
Photo: Getty Images